piracetam has been researched along with Amyloid Angiopathy, Cerebral in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García Estévez, DA | 1 |
| García-Dorrego, RM | 1 |
| Nieto-Baltar, B | 1 |
| Marey-Garrido, M | 1 |
| Hierro-Torner, T | 1 |
1 other study available for piracetam and Amyloid Angiopathy, Cerebral
| Article | Year |
|---|---|
Spontaneous convexity subarachnoid haemorrhage: Clinical series of 3 patients with associated cerebral amyloid angiopathy.
Topics: Aged; Anticonvulsants; Brain; Cerebral Amyloid Angiopathy; Dexamethasone; Female; Glucocorticoids; H | 2017 |